Home - Products - Others - Other Targets - 7-hydroxy-4-methyl-8-nitrocoumarin

7-hydroxy-4-methyl-8-nitrocoumarin

CAS No. 19037-69-5

7-hydroxy-4-methyl-8-nitrocoumarin( —— )

Catalog No. M18166 CAS No. 19037-69-5

7-Hydroxy-4-methyl-8-nitrocoumarin is a coumarin derivative.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 29 In Stock
50MG 40 In Stock
100MG 67 In Stock
200MG Get Quote In Stock
500MG 164 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    7-hydroxy-4-methyl-8-nitrocoumarin
  • Note
    Research use only, not for human use.
  • Brief Description
    7-Hydroxy-4-methyl-8-nitrocoumarin is a coumarin derivative.
  • Description
    7-Hydroxy-4-methyl-8-nitrocoumarin is a coumarin derivative.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    19037-69-5
  • Formula Weight
    221.16
  • Molecular Formula
    C10H7NO5
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 5 mg/mL (22.61 mM)
  • SMILES
    CC1=CC(=O)OC2=C1C=CC(=C2[N+](=O)[O-])O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • BMS-P5 free base

    BMS-P5 free base is a specific and orally active peptidylarginine deiminase 4 (PAD4) inhibitor.?BMS-P5 Blocks Formation of Neutrophil Extracellular Traps and Delays Progression of Multiple Myeloma.

  • Ledipasvir acetone

    Ledipasvir (GS5885) is an HCV NS5A polymerase inhibitor, used for the treatment of hepatitis C virus infection.

  • Marginatoxin

    Marginatoxin may be a promising chemopreventive agent for treating hepatocellular carcinoma, it induces human hepatoma BEL-7402 cells apoptosis in vitro and in vivo via activation of Fas/FasL-mediated apoptotic pathway.